Article Details
Retrieved on: 2024-08-20 17:07:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The firm's analyst highlighted the company's second-quarter financial results for 2024 and provided an update on its gene therapy (GT) pipeline.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here